Press release
Glaucoma Market Forecasted to Reach USD 6.9 Billion by 2034
Glaucoma
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72297
With the growing burden of aging populations, rising prevalence of diabetes, and increased awareness of eye health, the glaucoma patient pool continues to expand. This presents significant opportunities for early diagnosis, treatment, and management using advanced therapies like anti-VEGF injections, minimally invasive glaucoma surgery (MIGS), and sustained-release implants.
Market Overview
• Market Size (2024): USD 3.2 billion
• Forecast (2034): USD 6.9 billion
• CAGR (2025-2034): 8.1%
Key Highlights:
• Glaucoma prevalence projected to increase significantly by 2034, especially in aging populations.
• Anti-VEGF therapies, MIGS, and drug delivery implants are expected to reshape the treatment landscape.
• The market for early screening tools and tele-ophthalmology is expanding.
• AI diagnostics and genetic screening are improving early detection and personalized care.
Segmentation Analysis
By Type of Glaucoma:
• Primary Open-Angle Glaucoma (POAG)
• Angle-Closure Glaucoma
• Secondary Glaucoma
• Congenital Glaucoma
By Treatment Type:
• Medications
o Prostaglandin Analogs (dominant)
o Beta-Blockers
o Alpha-Agonists
o Carbonic Anhydrase Inhibitors
o Combination Therapies
• Surgical Interventions
o Trabeculectomy
o MIGS (Minimally Invasive Glaucoma Surgery - fastest-growing)
o Glaucoma Drainage Devices
• Sustained-Release Implants
o Bimatoprost SR
o Dexamethasone implants
• Laser Treatments
o Selective Laser Trabeculoplasty (SLT)
o Argon Laser Trabeculoplasty (ALT)
By End Use:
• Hospitals & Specialty Clinics
• Ambulatory Surgical Centers
• Online Pharmacies
• Research & Academic Institutes
Segmentation Summary:
Medications remain the primary treatment, but MIGS and sustained-release implants are expected to grow rapidly due to their convenience and efficacy, especially for patients with high treatment adherence needs.
Explore Full Report here: https://exactitudeconsultancy.com/reports/72297/glaucoma-patient-pool-analysis-market
Regional Analysis
North America
• Largest market (~44% share in 2024).
• High prevalence of glaucoma due to aging populations and high diabetes rates.
• Strong adoption of MIGS, anti-VEGF therapies, and long-acting implants.
Europe
• ~32% share.
• Germany, UK, and France leading in glaucoma care.
• Increasing investment in AI-based screening and clinical trials for new treatments.
Asia-Pacific
• Fastest-growing region, CAGR ~9.4%.
• High glaucoma burden in China, India, and Southeast Asia due to aging and increasing diabetes cases.
• Expanding adoption of tele-ophthalmology and glaucoma screening programs.
Latin America
• Brazil and Mexico strengthening ophthalmology infrastructure and glaucoma awareness.
Middle East & Africa
• GCC nations advancing glaucoma care systems.
• Higher unmet need in sub-Saharan Africa due to limited access to advanced treatments.
Regional Summary:
North America and Europe lead in innovation and adoption of advanced treatments, while Asia-Pacific is expected to witness the highest growth due to its large patient base and expanding healthcare infrastructure.
Market Dynamics
Key Growth Drivers:
• Increasing global prevalence of glaucoma, particularly in aging populations.
• Advancements in MIGS, laser treatments, and sustained-release drug delivery systems.
• AI-based diagnostic tools improving early detection rates and diagnosis accuracy.
• Expanding screening programs and tele-ophthalmology services in underserved regions.
Key Challenges:
• High costs of advanced treatments such as MIGS, sustained-release implants, and anti-VEGF therapies.
• Lack of awareness and underdiagnosis of glaucoma, especially in rural areas.
• Side effects of long-term corticosteroid use in glaucoma management.
• Global disparities in access to high-quality care, particularly in low-income countries.
Latest Trends:
• Tele-ophthalmology allowing remote diagnosis and management of glaucoma, especially in rural areas.
• AI-powered imaging for early diagnosis and personalized treatment.
• Ongoing clinical trials for neuroprotective therapies aimed at preserving optic nerve function.
• Development of non-invasive monitoring devices for intraocular pressure (IOP) at home.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72297
Competitor Analysis
Major Players in the Market:
• Novartis AG (Alcon - glaucoma portfolio)
• AbbVie Inc. (Allergan - Lumigan, Combigan)
• Santen Pharmaceutical Co., Ltd.
• Bausch + Lomb
• Johnson & Johnson Vision Care (MIGS devices)
• Glaukos Corporation (iStent, MIGS leader)
• Iridex Corporation (laser systems)
• Regeneron Pharmaceuticals, Inc.
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
Competitive Summary:
Novartis, AbbVie, and Alcon dominate glaucoma drugs and surgical treatments, while Glaukos and Johnson & Johnson Vision are leaders in MIGS devices. Santen, Bausch + Lomb, and Iridex provide complementary glaucoma solutions, particularly for laser therapy and advanced surgical devices.
Conclusion
The Glaucoma Patient Pool Analysis Market, valued at USD 3.2 billion in 2024, is projected to reach USD 6.9 billion by 2034, expanding at a CAGR of 8.1%.
Key Takeaways:
• Medications remain essential, but MIGS and sustained-release implants are transforming the market.
• North America and Europe lead in adoption, but Asia-Pacific shows the fastest growth.
• Advances in AI diagnostics, tele-ophthalmology, and precision-based treatments will drive future demand.
• Improved screening, accessibility, and affordability will reduce the global burden of glaucoma-related blindness.
The glaucoma market will continue its transition from symptomatic management to long-acting, precision-driven treatments aimed at early intervention and preservation of vision for millions of patients worldwide.
This report is also available in the following languages : Japanese (緑内障患者プール分析、市場), Korean (녹내장 환자 풀 분석, 시장), Chinese (青光眼患者群体分析、市场), French (Analyse du bassin de patients atteints de glaucome et du marché), German (Glaukom-Patientenpoolanalyse, Markt), and Italian (Analisi del bacino di pazienti affetti da glaucoma, mercato), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72297/glaucoma-patient-pool-analysis-market#request-a-sample
Our More Reports:
Back of the Eye Disorders Market
https://exactitudeconsultancy.com/reports/73154/back-of-the-eye-disorders-market
Cancer Stem Cell Therapies Market
https://exactitudeconsultancy.com/reports/73155/cancer-stem-cell-therapies-market
Non-Antibody Protein Scaffolds Market
https://exactitudeconsultancy.com/reports/73156/non-antibody-protein-scaffolds-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glaucoma Market Forecasted to Reach USD 6.9 Billion by 2034 here
News-ID: 4195913 • Views: …
More Releases from Exactitude Consultancy
North America ERCP and PTC Devices Market Expected to Grow at 8.1% CAGR
Introduction
Biliary and pancreatic disorders such as gallstones, strictures, bile duct cancers, and pancreatitis represent significant healthcare challenges in North America. Diagnostic and therapeutic interventions like Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) have become indispensable in managing these conditions.
Both procedures require advanced devices - including endoscopes, catheters, guidewires, stents, and balloon dilators - designed for precision and minimally invasive treatment. Rising prevalence of gastrointestinal (GI) cancers, an aging…
Uveitis Market Forecasted to Reach USD 4.1 Billion by 2034
Uveitis is an inflammatory eye disease that affects the uvea, the middle layer of the eye. It can lead to symptoms such as pain, redness, blurred vision, and sensitivity to light, and can result in retinal damage, cataracts, glaucoma, and permanent vision loss if left untreated. Uveitis can be caused by a variety of factors, including autoimmune diseases (e.g., rheumatoid arthritis, sarcoidosis), infections, and trauma, and may affect either one…
North America Gastric Bands and Balloons Market Projected to Grow at 7.5% CAGR
Introduction
Obesity has become a critical public health challenge in North America, with rising prevalence rates leading to increased risks of diabetes, cardiovascular disease, and other chronic conditions. As healthcare systems focus on preventive care and weight management, demand for bariatric interventions has surged. Among the available options, gastric bands and balloons have gained popularity as effective, minimally invasive treatments for obesity.
These devices provide an alternative to traditional bariatric surgery by…
Retinitis Pigmentosa Market Forecasted to Reach USD 4.5 Billion by 2034
Retinitis pigmentosa (RP) is a genetically heterogeneous group of inherited retinal diseases that cause progressive degeneration of the retina, primarily affecting the photoreceptor cells. It leads to progressive vision loss, starting with night blindness and peripheral vision loss and eventually advancing to central vision loss. RP is a leading cause of blindness in young adults, with a global prevalence of 1 in 4,000 individuals.
Download Full PDF Sample Copy of Market…
More Releases for Glaucoma
Glaucoma Surgery Devices Market Report 2024 - Glaucoma Surgery Devices Market Si …
"The Business Research Company recently released a comprehensive report on the Global Glaucoma Surgery Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The glaucoma surgery devices…
Global Glaucoma Market
According to a new market research report published by Global Market Estimates, the Global Glaucoma Market is projected to grow at a CAGR value of 5.0% from 2023 to 2028.
Growing awareness for early diagnosis of glaucoma have gained prominence due to various educational campaigns and screening programs. Early detection allows for timely intervention, leading to better disease management and reducing the risk of vision loss, thus propelling the market growth.…
Glaucoma Treatment Market - Safeguarding Sight: Innovating Glaucoma Treatment fo …
Newark, New Castle, USA: The "Glaucoma Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Glaucoma Treatment Market: https://www.growthplusreports.com/report/glaucoma-treatment-market/8926
This latest report researches the industry structure, sales, revenue,…
Glaucoma Surgical Devices Market By Device Type (Glaucoma Drainage Devices, Impl …
Glaucoma Surgical Devices market report presents a global overview of market shares, size, statistics, trends, demand, revenue and growth opportunities by key players, regions and countries. This report offers a complete market overview during the past, present, and the forecast period till 2032 which helps to identify future opportunities, risk factors, growing areas. Report also highlight on recent developments, technological innovations, market affecting factors, demographics analysis, demand and supply chain…
Micro-Invasive Glaucoma Implants Micro-Invasive Glaucoma Implants
Global Micro-Invasive Glaucoma Implants Market Definition: Micro-invasive glaucoma implants is performed for the treatment of the open- angle glaucoma and is done through an ab- interno approach. It is very safe and provides faster recovery as compared to the traditional methods. They usually lower the intraocular by increasing the flow or reducing the production of the aqueous humor. Increasing cases of the glaucoma worldwide is the major factor fueling the…
Glaucoma Surgery Devices Market 2016: Glaucoma Systems, Glaucoma Laser Devices
Latest industry research report on Glaucoma surgery devices are used in the glaucoma treating procedure. These procedures include both surgical and laser therapies performed on a patient. The cases of blindness due to glaucoma is on rise across the several countries. Furthermore, the demand for both technologically as well as advanced surgical equipment has resulted in the popularity of glaucoma surgery devices industry, worldwide.
Sudden increase in the aging population and…
